Cindy Wakefield

996 total citations
24 papers, 664 citations indexed

About

Cindy Wakefield is a scholar working on Hematology, Genetics and Speech and Hearing. According to data from OpenAlex, Cindy Wakefield has authored 24 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 4 papers in Genetics and 4 papers in Speech and Hearing. Recurrent topics in Cindy Wakefield's work include Platelet Disorders and Treatments (13 papers), Hemophilia Treatment and Research (10 papers) and Blood groups and transfusion (8 papers). Cindy Wakefield is often cited by papers focused on Platelet Disorders and Treatments (13 papers), Hemophilia Treatment and Research (10 papers) and Blood groups and transfusion (8 papers). Cindy Wakefield collaborates with scholars based in Canada, United Kingdom and United States. Cindy Wakefield's co-authors include Victor S. Blanchette, Nancy L. Young, Patricia McCusker, Catharine S. Bradley, Dorothy Barnard, Manuel Carção, John K. Wu, Robert J. Klaassen, Margaret L. Rand and Christine Curtis and has published in prestigious journals such as Blood, The Journal of Pediatrics and British Journal of Haematology.

In The Last Decade

Cindy Wakefield

23 papers receiving 655 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cindy Wakefield Canada 14 528 78 71 66 63 24 664
Seira Kurian United States 8 466 0.9× 127 1.6× 65 0.9× 40 0.6× 12 0.2× 14 667
María Eva Mingot‐Castellano Spain 16 689 1.3× 47 0.6× 192 2.7× 64 1.0× 12 0.2× 74 874
N. N. Kuzmina Russia 6 532 1.0× 97 1.2× 18 0.3× 143 2.2× 249 4.0× 24 686
Diana Milojevic United States 12 381 0.7× 156 2.0× 15 0.2× 127 1.9× 216 3.4× 24 579
M.L. te Winkel Netherlands 15 156 0.3× 31 0.4× 50 0.7× 96 1.5× 53 0.8× 25 764
Karen N. Watanabe Duffy Canada 8 177 0.3× 81 1.0× 12 0.2× 54 0.8× 127 2.0× 12 442
Mohan Pai Canada 8 195 0.4× 27 0.3× 49 0.7× 24 0.4× 33 0.5× 11 416
İnci Alacacıoğlu Türkiye 12 123 0.2× 49 0.6× 61 0.9× 43 0.7× 10 0.2× 46 383
Caroline Flurey United Kingdom 12 163 0.3× 63 0.8× 29 0.4× 25 0.4× 11 0.2× 39 512
Christina J. Bemrich‐Stolz United States 9 191 0.4× 64 0.8× 83 1.2× 38 0.6× 94 1.5× 20 324

Countries citing papers authored by Cindy Wakefield

Since Specialization
Citations

This map shows the geographic impact of Cindy Wakefield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cindy Wakefield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cindy Wakefield more than expected).

Fields of papers citing papers by Cindy Wakefield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cindy Wakefield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cindy Wakefield. The network helps show where Cindy Wakefield may publish in the future.

Co-authorship network of co-authors of Cindy Wakefield

This figure shows the co-authorship network connecting the top 25 collaborators of Cindy Wakefield. A scholar is included among the top collaborators of Cindy Wakefield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cindy Wakefield. Cindy Wakefield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wakefield, Cindy, et al.. (2024). Identifying hemophilia B carriers: Utility of aPTT, factor IX levels and ratios of factor IX to other Vitamin K dependent factors. Haemophilia. 30(4). 1003–1009. 1 indexed citations
2.
3.
Young, Nancy L., Victor S. Blanchette, Robert J. Klaassen, et al.. (2021). Measuring the impact of hemophilia on families: Development of the Hemophilia Family Impact Tool (H‐FIT). Research and Practice in Thrombosis and Haemostasis. 5(4). e12519–e12519. 3 indexed citations
4.
Maguire, Bryan, et al.. (2021). Excess weight gain in the paediatric bleeding disorders population: Impact of the COVID‐19 Pandemic. Haemophilia. 28(1). 91–96. 1 indexed citations
5.
Price, Victoria, Victor S. Blanchette, Robert J. Klaassen, et al.. (2021). Updating the Canadian Hemophilia Outcomes–Kids’ Life Assessment Tool (CHO‐KLAT) in the era of extended half‐life clotting factor concentrates. Research and Practice in Thrombosis and Haemostasis. 5(3). 403–411. 6 indexed citations
6.
Labarque, Veerle, et al.. (2016). The Factor VIII to Von Willebrand Factor Antigen (FVIII/VWF:Ag) ratio could be helpful in identifying carriers of hemophilia A. Haemophilia. 22(4). 16. 1 indexed citations
7.
Young, Nancy L., et al.. (2013). Updating the Canadian Hemophilia Outcomes–Kids Life Assessment Tool (CHO-KLAT Version2.0). Value in Health. 16(5). 837–841. 23 indexed citations
8.
Grainger, John D., Nancy L. Young, Victor S. Blanchette, et al.. (2013). Quality of life in immune thrombocytopenia following treatment. Archives of Disease in Childhood. 98(11). 895–897. 16 indexed citations
9.
Klaassen, Robert J., Victor S. Blanchette, Tricia A. Burke, et al.. (2012). Quality of life in childhood immune thrombocytopenia: International validation of the kids' ITP tools. Pediatric Blood & Cancer. 60(1). 95–100. 32 indexed citations
10.
Biss, Tina, Victor S. Blanchette, Dewi Clark, et al.. (2010). Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire. Journal of Thrombosis and Haemostasis. 8(5). 950–956. 99 indexed citations
11.
Price, Victoria, Robert J. Klaassen, Paula Bolton‐Maggs, et al.. (2009). Measuring disease-specific quality of life in rare populations: a practical approach to cross-cultural translation. Health and Quality of Life Outcomes. 7(1). 92–92. 46 indexed citations
12.
Biss, Tina, Victor S. Blanchette, Dewi Clark, et al.. (2009). Evaluation of Bleeding Symptoms in Children with An Inherited Mucocutaneous Bleeding Disorder.. Blood. 114(22). 1292–1292. 2 indexed citations
13.
Klaassen, Robert J., Victor S. Blanchette, Dorothy Barnard, et al.. (2007). Validity, Reliability, and Responsiveness of a New Measure of Health-Related Quality of Life in Children with Immune Thrombocytopenic Purpura: The Kids’ ITP Tools. The Journal of Pediatrics. 150(5). 510–515.e1. 64 indexed citations
14.
Bradley, Catharine S., Monika Bullinger, Patricia McCusker, et al.. (2006). Comparing two measures of quality of life for children with haemophilia: the CHO‐KLAT and the Haemo‐QoL. Haemophilia. 12(6). 643–653. 30 indexed citations
15.
Young, Nancy L., Catharine S. Bradley, Cindy Wakefield, et al.. (2005). How well does the Canadian haemophilia Outcomes‐Kids' Life Assessment Tool (CHO‐KLAT) measure the quality of life of boys with haemophilia?. Pediatric Blood & Cancer. 47(3). 305–311. 57 indexed citations
16.
Young, Nancy L., Catharine S. Bradley, Victor S. Blanchette, et al.. (2004). Development of a health‐related quality of life measure for boys with haemophilia: the Canadian Haemophilia Outcomes – Kids Life Assessment Tool (CHO‐KLAT). Haemophilia. 10(s1). 34–43. 76 indexed citations
17.
Barnard, Dorothy, David Feeny, Patricia McCusker, et al.. (2003). Development of Disease-Specific Health-Related Quality-of-Life Instruments for Children With Immune Thrombocytopenic Purpura and Their Parents. Journal of Pediatric Hematology/Oncology. 25(1). 56–62. 44 indexed citations
18.
Carção, Manuel, Victor S. Blanchette, Derek Stephens, et al.. (2002). Assessment of thrombocytopenic disorders using the Platelet Function Analyzer (PFA‐100®)*. British Journal of Haematology. 117(4). 961–964. 23 indexed citations
19.
Semple, John W., David J. Allen, Mary Rutherford, et al.. (2002). Anti‐D (WinRho SD™) treatment of children with chronic autoimmune thrombocytopenic purpura stimulates transient cytokine/chemokine production. American Journal of Hematology. 69(3). 225–227. 26 indexed citations
20.
Carção, Manuel, et al.. (2002). Fcγ receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura. British Journal of Haematology. 120(1). 135–141. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seira Kurian Breakdown of academic impact, for papers by María Eva Mingot‐Castellano Breakdown of academic impact, for papers by N. N. Kuzmina Breakdown of academic impact, for papers by Diana Milojevic Breakdown of academic impact, for papers by M.L. te Winkel Breakdown of academic impact, for papers by Karen N. Watanabe Duffy Breakdown of academic impact, for papers by Mohan Pai Breakdown of academic impact, for papers by İnci Alacacıoğlu Breakdown of academic impact, for papers by Caroline Flurey Breakdown of academic impact, for papers by Christina J. Bemrich‐Stolz
Rankless by CCL
2026